JPH0260659A - Body fluid filter device - Google Patents

Body fluid filter device

Info

Publication number
JPH0260659A
JPH0260659A JP63214170A JP21417088A JPH0260659A JP H0260659 A JPH0260659 A JP H0260659A JP 63214170 A JP63214170 A JP 63214170A JP 21417088 A JP21417088 A JP 21417088A JP H0260659 A JPH0260659 A JP H0260659A
Authority
JP
Japan
Prior art keywords
body fluid
filtration
bag
films
filtrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63214170A
Other languages
Japanese (ja)
Inventor
Akira Yagishita
柳下 明
Tatsuya Fujii
立哉 藤井
Takaaki Osawa
孝明 大澤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP63214170A priority Critical patent/JPH0260659A/en
Publication of JPH0260659A publication Critical patent/JPH0260659A/en
Pending legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)

Abstract

PURPOSE:To obtain the body fluid filter device which has a small priming volume and is reduced in size by constituting filtrate flow passages between the bag-shaped filtration films constituting the body fluid flow passages. CONSTITUTION:The body fluid filter device has the construction consisting in interposing plural sheets of the bag-shaped filtration films between filtrate flow passage forming bodies 5 or alternately stacking these films to provide the filtrate flow passages, housing these filtration films into the body case of the body fluid filter device provided with a body fluid inflow port 1, a body fluid outflow port 2 and a filtrate outflow port 3, and adhering a cap 10 via an O-ring 11 to the body case by ultrasonic sealing or adhesive agent. Each of the bag-shaped filtrate films 9 is formed by positioning two sheets of the filtration films 6 provided integrally with projecting parts on one surface so as to hold a diskshaped flat spacer 7 between the films in such a manner that the respective projecting parts face each other on the inner side and sealing the ends of the two filtration films to form the films to a bag shape. The bony fluid flow passages 21 are formed therein. The projecting parts have preferably 30 to 200mum, more particularly preferably 50 to 100mum height of the projecting parts. The flat plate spacer has preferably 10 Brinell hardness and 10 to 200mum thickness.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は、体液を分離する濾過装置に係り、特に血液を
濾過して血球と血漿とを分離する濾過装置に関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a filtration device for separating body fluids, and particularly to a filtration device for filtering blood to separate blood cells and plasma.

[従来の技術] 従来から、血液を分離する血漿分離装置が、血漿交換療
法等の医療分野で利用されている。このような血漿分離
装置としては、遠心分離装置及び膜分離装置が知られて
おり、特に装置及び操作の簡便さから膜分離装置が広く
用いられている。この膜分離装置は、中空糸型と平膜型
が代表的であり、中でも中空糸型と比較して濾過膜の材
質を広範に選択することができ、膜の安定性が高く且つ
濾過モジュールの形状を広範に選択することができ、し
かも小型で高性能な血漿分離装置を設計し得るという利
点を有している。
[Prior Art] Conventionally, plasma separation devices for separating blood have been used in medical fields such as plasma exchange therapy. Centrifugal separators and membrane separators are known as such plasma separators, and membrane separators are particularly widely used because of their ease of equipment and operation. Typical membrane separation devices are hollow fiber type and flat membrane type, and compared to the hollow fiber type, the material of the filtration membrane can be selected from a wider range, the membrane is highly stable, and the filtration module is It has the advantage that the shape can be selected from a wide range and that a compact and high-performance plasma separation device can be designed.

このような平膜型血漿分離装置としては、特開昭57−
25857号公報のように2枚の多孔質膜で支持体を挟
んで袋状に形成された多孔質濾過膜を、血液流路規制板
を一間に介在させて多数積層した構造を有する濾過装置
が知られている。この構造では、血液流路規制板を薄く
することによって小型化を計り得るが、これには限界が
ある。そこで、第3図に示すように、この凹凸を有する
流路規制板のかわりに、袋状の多孔質濾過膜の表面に凹
凸を設け、極薄い平板スペーサを介して該袋状濾過膜を
多数積層する試みがなされている。この血漿分離装置で
は、血液が体液流入口1から流入され、袋状濾過膜って
濾過されることによって血漿がその濾液として濾液流出
口から流出し、濾過されない溶液が体液流出口3から流
出するしくみになっている。しかしながら、このような
改良もまだ不十分である。
As such a flat membrane type plasma separator, Japanese Patent Application Laid-open No. 57-1980
A filtration device having a structure in which a large number of porous filtration membranes formed in a bag shape with a support sandwiched between two porous membranes are stacked with a blood flow path regulating plate interposed between them, as disclosed in Publication No. 25857. It has been known. Although this structure can be made smaller by making the blood flow path regulating plate thinner, there is a limit to this. Therefore, as shown in Fig. 3, instead of the flow path regulating plate having the unevenness, unevenness is provided on the surface of the bag-shaped porous filtration membrane, and a large number of the bag-shaped filtration membranes are connected to each other through an extremely thin flat plate spacer. Attempts have been made to stack them. In this plasma separation device, blood flows in through a body fluid inlet 1 and is filtered through a bag-like filtration membrane, so that plasma flows out as a filtrate through a filtrate outlet, and an unfiltered solution flows out through a body fluid outlet 3. It's structured. However, such improvements are still insufficient.

また、血漿分離装置を用いて献血時に血漿のみを採取す
る場合、供血者の安全を確保し、分離された血漿がブラ
イミング液で稀釈されるのを防止するため、血液分離装
置の血液側ブライミング容積を少なくすることが望まし
い。しかし、上述の構造の装置では、血液側ブライミン
グ容積の縮小は困難である。
In addition, when only plasma is collected during blood donation using a plasma separator, in order to ensure the safety of the donor and to prevent the separated plasma from being diluted with the briming solution, the blood side briming volume of the blood separator must be It is desirable to reduce the However, with the device having the above structure, it is difficult to reduce the blood side briming volume.

[発明が解決しようとする課題] 本発明は上記事情に鑑みてなされたもので、ブライミン
グ容積の小さい小型化された体液濾過装置を提供するこ
とを目的とする。
[Problems to be Solved by the Invention] The present invention has been made in view of the above circumstances, and an object of the present invention is to provide a miniaturized body fluid filtration device with a small briming volume.

[課題を解決するための手段] 本発明の体液濾過装置は、体液流入口、体液流出口及び
濾液流出口を設けた濾過装置本体ケース内に、体液流出
孔及び体液流入孔を有する複数の袋状濾過膜を重ね合わ
せて収納し、この本体ケースの体液流入口と各袋状濾過
膜の体液流入孔、及び本体ケースの体液流出口と各袋状
濾過膜の体液流出孔とを連通させてなる体液濾過装置に
おいて、前記袋状濾過膜が、体液流路を構成する袋状濾
過膜であり、各袋状a過膜の間に濾液流路を構成するこ
とを特徴とする。
[Means for Solving the Problems] The body fluid filtration device of the present invention includes a plurality of bags each having a body fluid outflow hole and a body fluid inflow hole in a filtration device body case provided with a body fluid inlet, a body fluid outlet, and a filtrate outlet. The body fluid inlet of the body case is communicated with the body fluid inlet of each bag-shaped filtration membrane, and the body fluid outlet of the body case is communicated with the body fluid outlet of each bag-shaped filtration membrane. In the body fluid filtration device, the bag-like filtration membrane is a bag-like filtration membrane that constitutes a body fluid flow path, and a filtrate flow path is configured between each bag-like a-filtration membrane.

本発明の体液濾過装置は、体液が体液流入口から直接体
液流路用空洞を有する袋状濾過膜内に流入され、この袋
状濾過膜において、濾過され袋状濾過膜から出た濾液が
本体ケースの濾液流出口を経て流出される経路と、濾過
されなかった体液が袋状濾過膜から体液流出口を経て流
出される経路とを有する。
In the body fluid filtration device of the present invention, body fluid flows directly from a body fluid inlet into a bag-like filtration membrane having a cavity for a body fluid flow path, and in this bag-like filtration membrane, the filtrate that has been filtered and comes out of the bag-like filtration membrane is passed through the body. It has a path through which the body fluid flows out through the filtrate outflow port of the case, and a path through which unfiltered body fluid flows out from the bag-like filtration membrane through the body fluid outflow port.

前記袋状濾過膜は対向面に多数の突状部を一体に有する
2枚の濾過膜をその両面が前記突状部に接するように平
板状スペーサを介在させてなる。
The bag-shaped filtration membrane is formed by interposing two filtration membranes each having a large number of protrusions on opposing surfaces with a flat spacer interposed so that both sides of the membranes are in contact with the protrusions.

前記突状部は凸部の高さが30〜200μmが好ましく
、特に50〜100μmが好ましい。この突状部の高さ
は、体液流路の厚みを規定する重要な因子である。濾過
工学的な見地から見て、凸部の高さが20μm未満では
、体液流路が薄くなり過ぎて、圧力損失が大きくなる傾
向があり、また200μmを越えると剪断速度を大きく
することができないため、十分な体液濾過が得られない
傾向がある。
The height of the protruding portion is preferably 30 to 200 μm, particularly preferably 50 to 100 μm. The height of this protrusion is an important factor that defines the thickness of the body fluid flow path. From the viewpoint of filtration engineering, if the height of the convex portion is less than 20 μm, the body fluid flow path becomes too thin and pressure loss tends to increase, and if it exceeds 200 μm, the shear rate cannot be increased. Therefore, there is a tendency that sufficient body fluid filtration cannot be obtained.

この高さは、一定であることが望ましいが必ずしも限定
されるものではなく、体液の流れ方向に沿って高さが段
階的に変化しても良い。
Although it is desirable that this height be constant, it is not necessarily limited, and the height may change stepwise along the flow direction of the body fluid.

また、濾過膜表面上の個々の凸部の間隔は、均一かつ安
定化した体液流路を形成するために、ff1fな因子の
一つである。すなわち、凸部間隔が300μm未満では
、有効膜面積の減少及び過度の圧力損失増加を引起こし
、逆に凸部間隔が2000μmを越えると、膜の微小な
歪み、撓みが生じて、均一かつ安定化した体液流路の確
保が困難となり、十分な性能が得られない。このことよ
り凸部間隔は、300〜2000μmが好ましく、特に
500〜!000μmが好ましい。凸部の分布状態は、
濾過膜全面にわたって均一であることが好ましいが、均
一な体液の流れを阻害するものでなければ特に限定され
るものではない。
Further, the distance between the individual convex portions on the surface of the filtration membrane is one of the important factors for forming a uniform and stable body fluid flow path. In other words, if the distance between the protrusions is less than 300 μm, the effective membrane area will decrease and the pressure loss will increase excessively, whereas if the distance between the convex portions exceeds 2000 μm, the membrane will be slightly distorted and bent, resulting in a uniform and stable membrane. It becomes difficult to secure a flow path for body fluids, and sufficient performance cannot be obtained. From this, the distance between the convex parts is preferably 300 to 2000 μm, particularly 500 to 2000 μm! 000 μm is preferred. The distribution state of the convex parts is
Although it is preferable that the thickness be uniform over the entire surface of the filtration membrane, it is not particularly limited as long as it does not inhibit the uniform flow of body fluids.

凸部の平均直径は、100μm未満では均一な流路を支
持形成することが難しく、また1000μmを越えると
占有面積が大きくなりすぎる傾向があることから、10
0〜1000μmが好ましい。
If the average diameter of the convex portion is less than 100 μm, it is difficult to support and form a uniform flow path, and if it exceeds 1000 μm, the occupied area tends to become too large.
0 to 1000 μm is preferable.

上J己酉状部付濾過膜の製造方法としては、濾過膜を製
膜するときに凸部パターンを凹版として刻みこんだ金属
ロール上にて濾過膜を製膜させ、膜表面に濾過膜材質と
同一の材質からなる凸状部を形成させる方法や凸部パタ
ーンを凹版として刻みこんだ金属ロールの該凹部に樹脂
をつけ、これを平滑な濾過膜上に照射する方法、あるい
はスクリーン印刷用版を用い、紫外線あるいは電子線硬
化型樹脂を用いて、平滑な濾過膜上に凸部パターンを印
刷し、その後紫外線あるいは電子線を照射して、これを
硬化せしめる方法等があげられるが、特に限定されるも
のではない。
As for the manufacturing method of the filtration membrane with self-containing rooster-shaped parts, when forming the filtration membrane, the filtration membrane is formed on a metal roll in which the convex part pattern is carved as an intaglio, and the filtration membrane material is applied to the membrane surface. A method of forming convex portions made of the same material as , a method of applying resin to the concave portions of a metal roll in which the convex pattern is carved as an intaglio, and irradiating this onto a smooth filter membrane, or a screen printing plate. Examples include a method in which a convex pattern is printed on a smooth filtration membrane using an ultraviolet ray or electron beam curable resin, and then the pattern is cured by irradiation with ultraviolet rays or an electron beam, but there are no particular limitations. It is not something that will be done.

前記平板状スペーサは、均一で安定な体液流路を確保す
るためには、硬質のものであることが好ましい。ここで
いう硬質の材質とは、膜表面の突状体と接触したとき、
へこみ等の変形を事実上起こさないものを指し、ブリネ
ル硬さ10以上のものをいう。この範囲のブリネル硬さ
をもつ材料としては、ポリエチレン、ポリプロピレン、
ポリエステル、ポリカーボネート等が好ましい。
The flat spacer is preferably hard in order to ensure a uniform and stable body fluid flow path. The hard material here means that when it comes into contact with the protrusions on the membrane surface,
This refers to a material that virtually does not cause deformation such as denting, and has a Brinell hardness of 10 or more. Materials with Brinell hardness in this range include polyethylene, polypropylene,
Polyester, polycarbonate, etc. are preferred.

このブリネル硬さの測定方法はJIS  22243に
従って次式によって求められる。
The Brinell hardness is determined by the following formula according to JIS 22243.

π Dh HB:ブリネル硬さ(Kg/B2) p  :n4球の重さ(K9 ) D =鋼球の径(a ) d :くぼみの直径(am ) h :くぼみの深さ(rut ) また、平板状流路規制体の厚みは、10μm未満では均
一な体液流路を支持形成することが難しく、200μ尻
を越えると、装置が大型化する傾向があることから、1
0〜200μmが好ましく、特に20〜60μmが好ま
しい。
π Dh HB: Brinell hardness (Kg/B2) p: Weight of n4 ball (K9) D = Diameter of steel ball (a) d: Diameter of hollow (am) h: Depth of hollow (rut) If the thickness of the flat flow path regulating body is less than 10 μm, it is difficult to support and form a uniform body fluid flow path, and if it exceeds 200 μm, the device tends to become larger.
The thickness is preferably 0 to 200 μm, particularly preferably 20 to 60 μm.

この平板状スペーサに用いられる材質としては、体液、
特に血液に対して適合性に優れたポリエチレン、ポリプ
ロピレン、ポリエステル、ポリカーボネート等が好まし
い。
Materials used for this flat spacer include body fluids,
Particularly preferred are polyethylene, polypropylene, polyester, polycarbonate, etc., which have excellent compatibility with blood.

[作用コ 従来は袋状濾過膜の外部に設けられていた体液流入路が
、本発明の体液濾過装置では体液流路用字/lt1とし
て袋状濾過膜の中に設けられているために、体液の装置
内における経路が次のように異なる。すなわち、従来の
体液濾過装置では、体液はまず袋状濾過膜外部に設けら
れた体液流入路に流入され、次に濾過膜において、濾過
された濾液は袋状a過膜及び濾液流出口を経て流出され
、一方、濾過されない体液は体液流出路及び体液流出口
を経て流出される。これに対し、本発明の体液濾過装置
では、体液はまず体液流入口から袋状a過膜内部の体液
流入路に流入され、次に濾過膜によって濾過された濾液
は濾液流路及び濾液流出口を経て流出され、一方、濾過
されない体液は、体液流路及び体液流出口を経て流出さ
れる。
[Function] Since the body fluid inflow path, which was conventionally provided outside the bag-like filtration membrane, is provided inside the bag-like filtration membrane as the body fluid flow path /lt1 in the body fluid filtration device of the present invention, The routes of body fluids within the device differ as follows. That is, in the conventional body fluid filtration device, body fluid first flows into a body fluid inflow path provided outside the bag-like filtration membrane, and then in the filtration membrane, the filtered filtrate passes through the bag-like a-filtration membrane and the filtrate outflow port. While the unfiltered body fluid is discharged through the body fluid outlet channel and the body fluid outlet. In contrast, in the body fluid filtration device of the present invention, the body fluid first flows from the body fluid inlet into the body fluid inlet path inside the bag-like a-filtration membrane, and then the filtrate filtered by the filtration membrane is transferred to the filtrate flow path and the filtrate outlet. , while unfiltered body fluid flows out through the body fluid channel and the body fluid outlet.

また従来では、本体ケース内の袋状濾過膜外部に満たさ
れる生理食塩水等のブライミング溶液は、本発明では袋
状濾過膜内部に満たされるのでその容量が減る。
Furthermore, in the present invention, the briming solution such as physiological saline, which is conventionally filled outside the bag-like filtration membrane in the main body case, is filled inside the bag-like filtration membrane, so its volume is reduced.

[実施例] 以下、実施例を示し、本発明を具体的に説明する。[Example] EXAMPLES Hereinafter, the present invention will be specifically explained with reference to Examples.

第1図は、本発明の一実施例に係る分離装置の構成を示
す図、第2図はその断面図である。第1図及び第2図に
おいて、体液濾過装置は、体液流入口1、体液流出口2
及び濾液流出口3が設けられた体液濾過装置本体ケース
20内に、複数枚の袋状濾過膜を濾液流路形成体5を間
に介在させ、交互に重ねることによって濾液流路を設け
て収納し、0リング11を介して蓋1oを超音波シール
または接着剤により接着した構造を有している。
FIG. 1 is a diagram showing the configuration of a separation device according to an embodiment of the present invention, and FIG. 2 is a sectional view thereof. In FIGS. 1 and 2, the body fluid filtration device includes a body fluid inlet 1 and a body fluid outlet 2.
A plurality of bag-shaped filtration membranes are stacked alternately with a filtrate flow path forming member 5 interposed therebetween, and a filtrate flow path is provided and stored in a body fluid filtration device main body case 20 in which a filtrate outlet 3 is provided. However, it has a structure in which the lid 1o is bonded via an O-ring 11 by ultrasonic sealing or adhesive.

前記袋状濾過膜9は、片面に突状部が一体に設けられた
2枚の濾過膜6を、それぞれの突状部が内側に対向する
ように、円形の平板状スペーサ7を挟み込むように位置
させ、両濾過膜の端部をシールして袋状としたもので、
その内部に体液流路21を形成している。濾液流路形成
体5、濾過膜6及び平板状スペーサ7は、それぞれ体液
流入孔5 a s 6 a s 7 a、及び体液流出
孔5b、6b。
The bag-like filtration membrane 9 includes two filtration membranes 6 each having a protrusion integrally provided on one side, with a circular flat spacer 7 sandwiched between the two filtration membranes 6 so that the protrusions face each other inwardly. The ends of both filtration membranes are sealed to form a bag.
A body fluid flow path 21 is formed inside thereof. The filtrate channel forming body 5, the filtration membrane 6, and the flat spacer 7 are respectively a body fluid inflow hole 5a, a 6a, and a body fluid outflow hole 5b, 6b.

7bを有している。各体液流入孔及び体液流出孔の周縁
部は、シール剤8、例えばホットメルト接着剤によりシ
ールされて連通され、体液流入路12及び体液流出路1
3を形成している。
7b. The peripheral edges of each body fluid inflow hole and body fluid outflow hole are sealed and communicated with a sealing agent 8, for example, a hot melt adhesive, and the body fluid inflow path 12 and the body fluid outflow path 1 are connected to each other.
3 is formed.

前記体液濾過M6は、平均孔径0,6μm1膜厚130
μmのポリプロピレーン製多孔質平膜の片面にスクリー
ン版を用いて紫外線硬化樹脂(大日本インキ社製、商品
名:ダイキュアMV)を所定のパターンにて印刷し、た
だちに該濾過膜に紫外線を照射して樹脂パターンを硬化
させることにより、高さ70μm1底部直径300μm
1間隔750μm1占有面積15%の均一な凸部が形成
されている。
The body fluid filtration M6 has an average pore diameter of 0.6 μm and a membrane thickness of 130
A predetermined pattern of ultraviolet curable resin (manufactured by Dainippon Ink Co., Ltd., product name: Daicure MV) is printed on one side of a μm polypropylene porous flat membrane using a screen plate, and the filtration membrane is immediately irradiated with ultraviolet rays. By curing the resin pattern, the height is 70 μm and the bottom diameter is 300 μm.
Uniform convex portions with an interval of 750 μm and an occupied area of 15% are formed.

前記体液流路形成体5は、目付215g/m2線径3デ
ニール、厚さ150μmのポリプロピレン製不繊布を3
枚重ねて用いられている。
The body fluid flow path forming body 5 is made of polypropylene nonwoven fabric having a basis weight of 215 g/m2, a wire diameter of 3 denier, and a thickness of 150 μm.
It is used in layers.

また、前記平板スペーサとしては、厚さ60μmの二軸
延伸ポリプロピレンフィルムが用いられている。
Further, as the flat plate spacer, a biaxially stretched polypropylene film having a thickness of 60 μm is used.

濾過装置本体ケース20は直径108zjs厚さ6.5
Mであり、袋状濾過膜9の積層数は11である。また、
濾過膜6及び体液流路形成体5は直径1041m、平板
状スペーサは直径968の円盤状である。一方、比較例
として用いた従来品の寸法は、体液濾過装置本体ケース
20は直径106 run及び厚さ6.5Mであり、濾
過膜6は直径104 m中央開孔部直径22amであり
、平板状スペーサは直径104B。
The filtration device main case 20 has a diameter of 108mm and a thickness of 6.5cm.
M, and the number of laminated bag-like filtration membranes 9 is 11. Also,
The filtration membrane 6 and body fluid channel forming body 5 have a diameter of 1041 m, and the flat spacer has a disc shape with a diameter of 968 m. On the other hand, the dimensions of the conventional product used as a comparative example are that the body fluid filtration device body case 20 has a diameter of 106 run and a thickness of 6.5 m, the filtration membrane 6 has a diameter of 104 m, a central opening diameter of 22 am, and a flat plate shape. The spacer has a diameter of 104B.

その中央開孔部直径22mであり、体液流路形成体は直
径98fl、中央開孔部30朋である。
Its central opening has a diameter of 22 m, and the body fluid flow path forming body has a diameter of 98 fl and a central opening of 30 mm.

上記形状を持つ本発明の体液濾過装置のブライミング容
積は13111であるのに対し、比較例のブライミング
容積は18Mであった。
The briming volume of the body fluid filtration device of the present invention having the above shape was 13111, whereas the briming volume of the comparative example was 18M.

さらに、この体液濾過装置を用いてACD、ヘパリン加
生血(ヘマトクリット40%)の濾過実験を行った。ヘ
パリン加生血を流m50m/分で濾過装置に流入し、体
液流出口と、濾液流出口の溶液の圧力が等しくなるよう
に濾液流出口の高さを調節して1分間の濾液流出量を測
定したところ、比較例20xtl1分、実施例22m1
1分と本発明の装置は従来の装置に比べて優れた体液分
離性能を示した。
Furthermore, a filtration experiment of ACD and heparinized blood (hematocrit 40%) was conducted using this body fluid filtration device. Heparinized blood flows into the filtration device at a flow rate of 50 m/min, and the height of the filtrate outlet is adjusted so that the pressure of the solution at the body fluid outlet and the filtrate outlet is equal, and the filtrate outflow amount for one minute is measured. As a result, Comparative Example 20xtl 1 minute, Example 22ml
1 minute, the device of the present invention showed superior body fluid separation performance compared to the conventional device.

[発明の効果] 本発明の体液濾過装置は、その性能を低下させることな
〈従来の体液濾過装置に比べ体液側プライミング溶液の
量を少なくすることができ、そのためより安全性の向上
を図ることができる。
[Effects of the Invention] The body fluid filtration device of the present invention can reduce the amount of priming solution on the body fluid side compared to conventional body fluid filtration devices without deteriorating its performance, thereby improving safety. Can be done.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は、本発明の一実施例を示す体液濾過装置の構成
を表わす図、第2図は、本発明の一実施例を示す体液濾
過装置の断面図、第3図は、従来例を示す体液濾過装置
の断面図である。 1・・・体液流入口、2・・・体液流出口、3・・・濾
液流出口、7・・・平板状スペーサ、9・・・袋状濾過
膜、20・・・濾過装置本体ケース
FIG. 1 is a diagram showing the configuration of a body fluid filtration device according to an embodiment of the present invention, FIG. 2 is a sectional view of a body fluid filtration device according to an embodiment of the present invention, and FIG. 3 is a diagram showing a conventional example. 1 is a cross-sectional view of the body fluid filtration device shown in FIG. DESCRIPTION OF SYMBOLS 1... Body fluid inlet, 2... Body fluid outlet, 3... Filtrate outlet, 7... Flat spacer, 9... Bag-shaped filtration membrane, 20... Filtration device main body case

Claims (4)

【特許請求の範囲】[Claims] (1)体液流入口、体液流出口及び濾液流出口を設けた
濾過装置本体ケース内に、体液流入孔及び体液流出孔を
有する複数の袋状濾過膜を重ね合わせて収納し、各袋状
濾過膜の体液流入孔と本体ケースの体液流入口、及び各
袋状濾過膜の体液流出孔と本体ケースの体液流出口とを
連通させてなる体液濾過装置であって、前記袋状濾過膜
は、その内部に体液流路を構成し、各袋状濾過膜の間に
濾過流路を構成したことを特徴とする体液濾過装置。
(1) A plurality of bag-shaped filtration membranes each having body fluid inflow holes and body fluid outflow holes are stacked and housed in a filtration device body case provided with a body fluid inlet, a body fluid outlet, and a filtrate outlet. A body fluid filtration device in which the body fluid inlet of the membrane and the body fluid inlet of the main body case are communicated, and the body fluid outlet of each bag-shaped filtration membrane and the body fluid outlet of the main body case are communicated, wherein the bag-shaped filtration membrane is A body fluid filtration device characterized in that a body fluid flow path is formed inside the body fluid filtration device, and a filtration flow path is formed between each bag-like filtration membrane.
(2)前記袋状濾過膜が、対向面に多数の突状部を一体
に有する2枚の濾過膜をその両面が前記突状部に接する
ように平板状スペーサを介在させてなることを特徴とす
る請求項1に記載の体液濾過装置。
(2) The bag-shaped filtration membrane is formed by interposing two filtration membranes having a plurality of protrusions integrally on opposing surfaces with a flat spacer interposed so that both sides of the membranes are in contact with the protrusions. The body fluid filtration device according to claim 1.
(3)前記突状部の凸部の高さが30〜200μmであ
る請求項2に記載の体液濾過装置。
(3) The body fluid filtration device according to claim 2, wherein the height of the convex portion of the protruding portion is 30 to 200 μm.
(4)前記平板状スペーサのブリネル硬度が10以上で
あり、厚さが10〜200μmである請求項3に記載の
体液濾過装置。
(4) The body fluid filtration device according to claim 3, wherein the flat spacer has a Brinell hardness of 10 or more and a thickness of 10 to 200 μm.
JP63214170A 1988-08-29 1988-08-29 Body fluid filter device Pending JPH0260659A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63214170A JPH0260659A (en) 1988-08-29 1988-08-29 Body fluid filter device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63214170A JPH0260659A (en) 1988-08-29 1988-08-29 Body fluid filter device

Publications (1)

Publication Number Publication Date
JPH0260659A true JPH0260659A (en) 1990-03-01

Family

ID=16651395

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63214170A Pending JPH0260659A (en) 1988-08-29 1988-08-29 Body fluid filter device

Country Status (1)

Country Link
JP (1) JPH0260659A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7284969B2 (en) 2003-09-24 2007-10-23 Jidosha Denki Kogyo Co., Ltd. Washer pump and filter used for washer pump

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7284969B2 (en) 2003-09-24 2007-10-23 Jidosha Denki Kogyo Co., Ltd. Washer pump and filter used for washer pump

Similar Documents

Publication Publication Date Title
US9421320B2 (en) Blood processing filter and the method for manufacturing the same
US4310416A (en) Plate type fluid treatment apparatus
US4323455A (en) Compact type fluid treatment apparatus
US4963260A (en) Liquid filtering device
JP5297463B2 (en) Blood processing equipment
EP2659917B1 (en) Blood processing filter
WO1988009200A1 (en) Flat film permeative membrane having protrusions, its production , and bodily fluid filter
US8851296B2 (en) Blood processing filter and the method for manufacturing the same
EP2659920B1 (en) Blood processing filter, and priming method for blood processing filter
WO2015050216A1 (en) Blood processing filter and blood processing method
JPH0260659A (en) Body fluid filter device
JP6559265B2 (en) Blood treatment filter
JPS62258708A (en) Flat-plate thin membrane laminate type filter
JPS6372305A (en) Bonding method for filter membrane of filter cartridge
JPH0299068A (en) Body fluid filtering apparatus
JPS6040304B2 (en) body fluid filtration device
JPH04144569A (en) Blood plasma separator
JP2022018673A (en) Blood treatment filter
JPH0245063A (en) Body fluid filter device
JPS5928966A (en) Serum separating apparatus
JPS6344909A (en) Filter cartridge
JPS5850963A (en) Serum separating apparatus
JPH0720539B2 (en) White blood cell separator
JPS6316146B2 (en)
JPH03146120A (en) Filtration membrane and filtration apparatus using the membrane